BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 12:13:00 PM | Browse: 1415 | Download: 1445
 |
Received |
|
2014-05-30 08:52 |
 |
Peer-Review Started |
|
2014-05-30 19:49 |
 |
To Make the First Decision |
|
2014-07-10 17:22 |
 |
Return for Revision |
|
2014-07-11 16:19 |
 |
Revised |
|
2014-07-12 21:25 |
 |
Second Decision |
|
2014-09-24 16:08 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-09-24 16:20 |
 |
Articles in Press |
|
2014-09-24 16:20 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-12-10 19:09 |
 |
Publish the Manuscript Online |
|
2014-12-18 14:44 |
Category |
Oncology |
Manuscript Type |
Review |
Article Title |
New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers
|
Manuscript Source |
Invited Manuscript |
All Author List |
Armel Hervé Nwabo Kamdje, Paul Faustin Seke Etet, Lorella Vecchio, Richard Simo Tagne, Jeremie Mbo Amvene, Jean-Marc Muller, Mauro Krampera and Kiven Erique Lukong |
Funding Agency and Grant Number |
|
Corresponding Author |
Armel Hervé Nwabo Kamdje, PhD, Department of Biomedical Sciences, Faculty of Sciences, University of Ngaoundere, PO Box 454, Ngaoundere,
Cameroon. armel.nwabo@gmail.com
|
Key Words |
Breast cancer; Microenvironment; Signaling molecule; Targeted therapy; Chemoresistance |
Core Tip |
Emerging therapeutic targets may overcome chemoresistance in breast cancer.
|
Publish Date |
2014-12-18 14:44 |
Citation |
Nwabo Kamdje AH, Seke Etet PF, Vecchio L, Tagne RS, Mbo Amvene J, Muller JM, Krampera M, Lukong KE. New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers. World J Clin Cases 2014; 2(12): 769-786 |
URL |
http://www.wjgnet.com/2307-8960/full/v2/i12/769.htm |
DOI |
http://dx.doi.org/10.12998/wjcc.v2.i12.769 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345